Yoshiharu Takagi

Efficacy and Safety of Alirocumab in Japanese Patients With Heterozygous Familial Hypercholesterolemia or at High Cardiovascular Risk With Hypercholesterolemia Not Adequately Controlled With Statins　– ODYSSEY JAPAN Randomized Controlled Trial –

Tamio Teramoto, Masahiko Kobayashi, Hiromi Tasaki et al. · Circulation Journal · 2016 · 128 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +17

Effect of Alirocumab on Coronary Atheroma Volume in Japanese Patients With Acute Coronary Syndrome　― The ODYSSEY J-IVUS Trial ―

Junya Ako, Kiyoshi Hibi, Kenichi Tsujita et al. · Circulation Journal · 2019 · 86 citations · Full text

Medicine, Cardiology, Pharmacotherapy +17

Efficacy and Safety of Alirocumab in Japanese Subjects (Phase 1 and 2 Studies)

Tamio Teramoto, Masahiko Kobayashi, Kiyoko Uno et al. · The American Journal of Cardiology · 2016 · 35 citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +17

Efficacy and Safety of Alirocumab in Japanese Patients with Diabetes Mellitus: Post-hoc Subanalysis of ODYSSEY Japan

Tamio Teramoto, Makiko Usami, Yoshiharu Takagi et al. · Journal of Atherosclerosis and Thrombosis · 2018 · 12 citations · Full text

Medicine, Cardiology, Pharmacotherapy +17